The case for vaccination in the face of the delta variant
Shirley Rooker talks with Thomas Firey, senior fellow at Cato, who discusses the COVID-19 vaccine and how the delta variant affects the need for the vaccine. He details the vigorous process used by the Food and Drug Administration to test new vaccines.